Back
EHRA Premium Access

Differences in anticoagulation strategy and outcome in patients with atrial fibrillation according to renal function

Session: Managing the thromboembolic risk in atrial fibrillation
Topic: Atrial Fibrillation - Epidemiology, Prognosis, Outcome
Event: EHRA 2018

Congress Presentation

6 more presentations in this session

Incidence of atrial arrhythmia and uptake of anticoagulation in stroke and non-stroke populations according to arrhythmia burden; a 7-year experience.

Speaker: Doctor P. Chousou (Cambridge, GB)

Access
Abstract
Slides
Thumbnail

Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials

Speaker: Doctor M. Proietti (Milan, IT)

Access
Abstract
Slides
Thumbnail

Incidence and predictors of left atrial appendage thrombus in patients treated with direct oral anticoagulants versus warfarin for non-valvular atrial fibrillation

Speaker: Doctor K. Minami (Utsunomiya, JP)

Access
Abstract
Slides
Thumbnail

Left atrial stunning as a predictor of atrial fibrillation occurrence after cryptogenic stroke

Speaker: Doctor J. Farinha (Setubal, PT)

Access
Abstract
Slides
Thumbnail

Indications for and outcome in patients undergoing left atrial appendage closure - Results of the Austrian LAAC Registry

Speaker: Mr D. Zweiker (Vienna, AT)

Access
Abstract
Slides
Thumbnail

Access the full session

Managing the thromboembolic risk in atrial fibrillation

Speakers: Doctor P. Chousou, Doctor M. Proietti, Doctor K. Minami, Doctor J. Farinha, Mr D. Zweiker
Access
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb